{
    "id": "5d384ce87bc3fee31f000013",
    "question": "Does GRHL2 over-expression lead to EMT?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "To answer this question, let's break down the process into steps: **Step 1: Understanding GRHL2 and EMT** GRHL2 (GATA4-related homeobox 2) is a transcription factor that plays a role in various biological processes, including embryonic development and cancer. EMT (Epithelial-to-Mesenchymal Transition) is a process where epithelial cells acquire a mesenchymal phenotype, losing their epithelial characteristics and gaining migratory and invasive properties. **Step 2: Role of GRHL2 in Cancer** GRHL2 has been identified as a tumor suppressor gene in various cancers, including breast, lung, and colon cancer. It regulates the expression of genes involved in cell proliferation, differentiation, and apoptosis. **Step 3: GRHL2 and EMT** Research has shown that GRHL2 can inhibit EMT by suppressing the expression of mesenchymal markers and promoting the expression of epithelial markers. In some studies, over-expression of GRHL2 has been associated with the suppression of EMT in cancer cells. **Step 4: Conclusion** Based on the available evidence, it appears that GRHL2 over-expression can lead to the suppression of EMT, rather than promotion. **Output:** ```json { \"step_by_step_thinking\": \"GRHL2 is a tumor suppressor gene that regulates various biological processes, including embryonic development and cancer. Over-expression of GRHL2 has been associated with the suppression of EMT in cancer cells, indicating that GRHL2 over-expression leads to EMT.\", \"answer_choice\": \"B\" } ``` Note: The answer is B.",
    "snippets": [],
    "scores": [],
    "execution_time": 36.277230978012085
}